Review
Open access
Jul 2026
The cancer/testis antigens represent promising targets for the development of new therapies against melanoma.
This review aims to critically analyze the immunogenic and oncogenic potential of CTAs, synthesize current preclinical and clinical evidence across distinct CTA subfamilies, and highlight innovative CTA-based immunotherapeutic strategies for the treatment of melanoma.
Suzana Lemke Lanius, B. Pacheco, Fernanda Severo Sabedra Sousa et al.
· Pathology, Research and Prac... · 0 citations